Prollenium breaks boundaries with launch of topical hyaluronidase

Published 19th Jul 2022
Prollenium breaks boundaries with launch of topical hyaluronidase

Prollenium® has announced the acquisition of Topilase®, the first brand of 100% natural topical hyaluronidase, describing it as "one of the most exciting innovations in cosmetic aesthetics in decades." 

Topilase® is the first topical hyaluronidase enabling treatment adjustment without injections. It is made of a combination of enzymes concentrated within a dispersing agent, helping it permeate the skin successfully, with the benefit of five additional natural ingredients – cistus, myrrh, lavender, aloe vera, and helichrysum essential oils to restore, soothe, purify, revitalise and regenerate.

The enzyme complex within Topilase® contains protease, lipase and hyaluronidase known to help break down HA chains. On average, patients require three treatments one week apart.

Topilase® is sold in 3ml bottles with a dosing tip for ease of application and minimal wastage. 

Ario Khoshbin, founder and CEO of Prollenium®, said, “Today we further demonstrate our commitment to providing best-in-class products to support safety, efficacy and expertise in the cosmetic aesthetics global market. We have made yet another exciting acquisition of this most exciting brand, and it is no exaggeration to say that Topilase® will likely revolutionise the practice of injectable enhancement, ensuring both patient safety and treatment outcome with a product that safely perfects treatment results completely non-invasively.” 

Paris-based Inventor of Topilase®, CEO, cosmetic doctor, international trainer, author and innovator, Dr Sandrine Sebban commented, “I am very proud of my most recent innovation, Topilase®. It was launched abroad last year and doctors have been trying it and been amazed at the results. There is no risk of an allergic reaction as it is not injected, so there are no side effects. Topilase® makes it easy to remove any flaw or unwanted HA. It’s won three awards, and I am very proud of that. It took five years to develop. Hyaluronidase can cause allergies, and people are worried about using it as it can create holes in the tissue. I wanted a topical product for that reason. It can take just a few minutes to work depending on how recent the product was injected but on average, it’s usually three sessions once a week for optimal results.” 

Prollenium®, which makes the injectable HA dermal filler brand Revanesse® and its portfolio of products, has also recently acquired SoftFil® microcannulas.

PB Admin

PB Admin

Published 19th Jul 2022

Have all the latest news delivered to your inbox